bioRxivCancer Biology
HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
S. Takahashi, A. Kanai, H. Okuda, R. Miyamoto, T. Kawamura, H. Matsui, T. Inaba, A. Takaori-Kondo, A. Yokoyama
Abstract
Leukemic oncoproteins cause uncontrolled self-renewal of hematopoietic progenitors by aberrant gene activation, eventually causing leukemia. However, the molecular mechanism of aberrant gene activation remains elusive. Here, we showed that leukemic MLL fusion proteins associate with the HBO1 histone acetyltransferase (HAT) complex through their TRX2 domain. Among many MLL fusions, MLL-ELL particularly depended on its association with the HBO1 complex for leukemic transformation. The C-terminal portion of ELL provided a binding platform for multiple factors including AF4, EAF1 and p53. MLL-ELL activated gene expression by loading an AF4 /ENL/P-TEFb complex (AEP) onto the target promoters. The HBO1 complex promoted the use of AEP over EAF1 and p53. Moreover, the NUP98-HBO1 fusion protein exerted its oncogenic properties via interaction with MLL but not its intrinsic HAT activity. Thus, the interaction between HBO1 and MLL is an important nexus in leukemic transformation, which may serve as a therapeutic target for drug development.
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MOZ and HBO1 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia
Nicole Lynn Michmerhuizen, Emily Heikamp, … Charles Grenfell Mullighan·Cancer DiscoveryPeer-reviewed·Jun 19, 2025
- PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
Nicholas T. Crump, Alastair Smith, … Thomas A. Milne·Nature CommunicationsPeer-reviewed·Aug 25, 2023
- HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways
R. Miyamoto, A. Kanai, … A. Yokoyama·bioRxiv·Oct 20, 2020
- Histone H3K36me2-specific methyltransferase ASH1L is required for the MLL-AF9-induced leukemogenesis
M. B. Aljazi, Y. Gao, … J. He·bioRxiv·Aug 5, 2021
- A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML
B. Chen, A. Deshpande, … A. Deshpande·bioRxiv·Aug 31, 2020
- Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in a Murine Model of T Acute Lymphoblastic Leukemia
T. Carr, S. McGregor, … B. L. Kee·bioRxiv·Nov 8, 2021